• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Drug Shortages

  • Print
  • Share
  • E-mail
-

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

 Daunorubicin Hydrochloride Solution for Injection

 Status: Currently in Shortage

 » Date first reported: No date available
 » Therapeutic Categories: Oncology; Pediatric

Bedford Laboratories (Reverified 07/09/2014)

Company Contact Information:
800-562-4797

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5 mg/mL, 4 mL single-dose vial (NDC 55390-0108-10) Unavailable Shortage: Pending Manufacturing Change or Addition. Availability of products are updated on the Bedford Laboratories website Other
10 mL single-dose vial (NDC 55390-0108-01) Unavailable Shortage: Pending Manufacturing Change or Addition. Availability of products are updated on the Bedford Laboratories website Other
Cerubidine lyophilized powder for injection, 20mg single-dose vial, package of 10 (NDC 55390-0281-10) Unavailable Shortage: Pending Manufacturing Change or Addition. Availability of products are updated on the Bedford Laboratories website Other

Teva Pharmaceuticals (Reverified 11/13/2014)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5 mg/mL, 4 mL single-dose vial (NDC 00703-5233-13) Product is currently available. Product is available and shipping. Other
-
-